Important note: Odyssey Acquisition S.A. will be renamed BenevolentAI following completion of the Business Combination and approval of the Prospectus, both scheduled for 22 April 2022. BenevolentAI’s securities will be admitted to Euronext Amsterdam on 25 April 2022. The final number of BenevolentAI securities to be admitted on Euronext Amsterdam will be provided on 22 April 2022, following approval of the Prospectus. Upon admisison of BenevolentAI’s securities on 25 April, this IPO Showcase page will be amended to reflect BenevolentAI’s information.

Identification
Listing sponsor / Agent

ABN AMRO BANK N.V.

Symbol
BAI
ISIN code
LU2355630455
LEI code
2221003P54KEDC3P4Z33
Exchange / Market
Euronext
Trading location
Amsterdam
Capitalization compartment
Compartment A
ICB
20103010 Biotechnology
Operation
IPO date
IPO type
SPAC – Business combination
Operation description

The final number of securities to be admitted to Euronext Amsterdam will be provided upon publication of the approved prospectus on 22 April, 2022